key: cord-0845425-xquiny0k
authors: Fitzpatrick, Courtney L; Alter, S Elizabeth; Boughman, Janette W; Débarre, Florence; Edmands, Suzanne; Moehring, Amanda; Moyle, Leonie; Otto, Sarah P; Ronce, Ophélie; Rubin, Matthew J; Sweigart, Andrea L
title: The virus evolves: four public health priorities for reducing the evolutionary potential of SARS-CoV-2
date: 2021-04-10
journal: Bioscience
DOI: 10.1093/biosci/biab037
sha: b99eb7d5db84193d94a646f4795f3822d331730d
doc_id: 845425
cord_uid: xquiny0k

nan

Reduce case counts as much as possible. One of the most well established truths of evolution is that adaptive change is more likely when populations are larger. This means that a drastic reduction in infections by a combination of measures (restrictions on social gathering, masking, vaccination, etc.) will not only reduce illness and save lives in the face of variants that are already present, it will guard against the conditions that favor the evolution of new variants of concern, which may be more transmissible, more virulent, or more able to escape immunity.

The transmission events most likely to select for escape variants are the transmissions from infectious to resistant individuals (either naturally infected or vaccinated) and from those individuals onward. Although transmissions between infectious and resistant individuals may be rare, the possibility of resistant mutations occurring and being passed on becomes more likely with large numbers of infections. Therefore, as vaccination campaigns proceed, it is critical that vaccinated people adhere to the same strong mitigation measures as unvaccinated people where risks of transmission remain high.

Genomic surveillance (regular sequencing of a representative sample of cases) is essential for identifying the emergence of new variants. Sharing these sequence data on public repositories as quickly as possible will enable rapid responses when new variants of concern are detected [6] . Moreover, genomic data should be paired with patient metadata so that any variants that alter the disease characteristics can be identified. Concurrent with genomic surveillance, increased genotyping of samples from cases for known variants of concern (e.g., via RT-PCR, which can return test results very quickly) is needed for rapid detection so that targeted control efforts can be put in place around those cases [7] .

We all live on the same planet. Leaving the epidemic uncontrolled anywhere leaves the global population vulnerable to the evolution of variants that can escape immunity. Therefore, we support the scientific consensus calling for global coordination on both vaccination campaigns and genomic surveillance

We ask leaders to seize this window of opportunity; protect the health of citizens and economies by taking swift action to guard against the threat of ongoing viral evolution [8] .

The Society for the Study of Evolution and American Society of Naturalists Joint Public Policy Committee:

Transmission of SARS-CoV-2 Lineage B. 1.1. 7 in England: Insights from linking epidemiological and genetic data

Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England

CMMID COVID-19 Working Group. et al. Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7

Perspective: The evolutionary dangers of high COVID case counts

Evolution goes viral

Public health actions to control new SARS-CoV-2 variants

Tracking the UK SARS-CoV-2 Outbreak